- Record: found
- Abstract: found
- Article: not found
Hereditary-like urothelial carcinomas of the upper urinary tract benefit more from adjuvant cisplatin-based chemotherapy after radical nephroureterectomy than do sporadic tumours.
Clémence Hollande
1 ,
Pierre Colin ,
Thibault de La Motte Rouge ,
François Audenet ,
David R Yates ,
Véronique Phé ,
Adil Ouzzane ,
Stéphane Droupy ,
Alain Ruffion ,
Alexandre de La Taille ,
Laurent Guy ,
Olivier Cussenot ,
François Rozet ,
Evanguelos Xylinas ,
Marc Zerbib ,
Jean-Philippe Spano ,
David Khayat ,
Marc-Olivier Bitker ,
Morgan Rouprêt
Apr 2014
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To evaluate the impact of 'hereditary-like' status in upper tract urothelial carcinoma (UTUC) on the survival of patients who have undergone radical nephroureterectomy (RNU) and adjuvant chemotherapy.